🔗 Share this article

An underground market for unlicensed weight-loss medications is being driven by social media fitness personalities and sellers on communication apps, based on recent findings.

Experimental Treatment Gaining Traction Online

Retatrutide, which remains in research studies, is being promoted by online personalities for its alleged fat-burning effects. Viewers are encouraged to message these profiles directly for supplier links, while also receiving discount codes.

Thriving Commerce on Messaging Platforms

Separately, a robust trade exists on messaging services, where communities with thousands of participants share comparison images, administration instructions and claims of next-day UK delivery. Sellers market the substance there before directing customers to other platforms for transactions.

Understanding Retatrutide

This medication is an experimental injectable developed by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.

Healthcare Professionals Voice Worries

Nevertheless, doctors and pharmacists have warned that the sale of what remains an unapproved medication in the UK is a cause for concern and could lead to individuals injecting substances of unknown origin.

Several professionals stated the demand for retatrutide could be linked to the rising cost of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unlicensed medication that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some content creators try to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still violate medicines, advertising, and consumer laws, potentially leading to fines, legal action or prison.

Service Reaction and Content Removal

According to TikTok, the platform has taken down problematic content and banned associated hashtags and query recommendations. The organization stated it was dedicated to maintaining the platform secure and investing in enhancing compliance measures.

Online Trading Operations

Research also found groups with up to 9,000 members marketing retatrutide using the platform's integrated search feature, which operates like a public directory. Entering “retatrutide” immediately brings up channels with numerous of members, filled with photos of slimming results, positive testimonials and step-by-step guides for preparing or injecting at home.

Within moments of joining one group, a seller shared WhatsApp details, where most purchases take place. The vendor provided an instruction manual and promised shipping within 48 hours. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None asked about weight, health issues or previous experience.

Product Information and Pricing

Inside these groups, messages show dark colored packages with Royal Mail stickers, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at residence with sterile water, or ready-to-use pens usually sold at £160 for 20mg. When questioned how long a pen should be used, sellers give conflicting responses varying between a few weeks to “depends on your body”.

Platform Moderation and Security Measures

A spokesperson for the messaging service said it actively monitored dangerous content on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are administering materials they can’t verify. Although the science behind this drug is sound, these digital products may not include what they advertise,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in demand to current price rises for approved weight-loss medications such as Mounjaro. “With costs increasing, patients are using online platforms. But fake injections are extremely dangerous. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she explained.

Her staff has previously encountered individuals injured by self-injection from unconfirmed sources. “We recognize the disappointment, but purchasing from Telegram or communication platforms is gambling with your health,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”

Producer Statement

A representative from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this point no one can sell [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a Lilly experimental product not yet authorized … may subject users to possibly significant health risks”.